CompletedObservationalLast updated Feb 1, 2017

A Retrospective Chart Review of Thirty Three Children Who Have Received Clinical Treatment With Either Romiplostim or Eltrombopag From 2009-2013

Overview

ClinicalTrials.gov ID: NCT01974232
Lead Sponsor: Weill Medical College of Cornell UniversityOTHER
Brief Summary: This is a retrospective analysis of children (≤21years old) who received clinical treatment with either Romiplostim or Eltrombopag at 2 medical centers from 2009-2013. The children included in this study were from Weill Medical College of Cornell University, New York, New York and Children's Hospital Orange County, Orange, California
Study Type

Status

Overall Status: Completed
Start Date: Jan 2012
Primary Completion Date: Jun 2013Actual
Completion Date: Jun 2013Actual

Study Record Dates

First Submitted: Oct 25, 2013
First Submitted that Met QC Criteria: Oct 25, 2013
First Posted: Nov 1, 2013Estimated
Last Update Submitted that Met QC Criteria: Jan 30, 2017
Last Update Posted: Feb 1, 2017Estimated
Last Verified: Jan 2017

NCT02279173Completed

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

NCT01071954Completed

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura

NCT04350164Completed

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

NCT01444417Completed

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

NCT01013181Completed

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

NCT01443351Withdrawn

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)